These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 723053)

  • 1. [Effects of prostaglandin-E1 on patients with pulmonary atresia (author's transl)].
    Usui K; Kuroda N; Matsukawa S; Sato M; Fukuda M; Ishizawa E
    Kyobu Geka; 1978 Dec; 31(12):908-11. PubMed ID: 723053
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of prostaglandin E1 on the hemodynamics in newborn infants with pulmonary atresia (author's transl)].
    Mocellin R; Sauer U; Schumacher G; Kellner M; Schöber JG
    Z Kardiol; 1978 Aug; 67(8):572-7. PubMed ID: 695809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M; Hövels-Gürich H; von Bernuth G
    Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E1 in infants with pulmonary atresia.
    Weir EK; Matisonn RE; Losman E; Chesler E
    S Afr Med J; 1978 Oct; 54(17):700-2. PubMed ID: 741285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
    Heymann MA; Rudolph AM
    Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K
    Ugeskr Laeger; 1979 Jul; 141(28):1915-6. PubMed ID: 473414
    [No Abstract]   [Full Text] [Related]  

  • 8. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus].
    Hruda J; Samánek M; First T; Vorísková M; Skovránek J
    Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases.
    Calder AL; Kirker JA; Neutze JM; Starling MB
    Pediatr Cardiol; 1984; 5(2):85-92. PubMed ID: 6591146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease.
    Lewis AB; Lurie PR
    Pediatrics; 1978 Apr; 61(4):534-6. PubMed ID: 662477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].
    van der Sijp JR; Rohmer J
    Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic maintenance of the ductus arteriosus.
    Freed MD
    Conn Med; 1982 Mar; 46(3):131-4. PubMed ID: 7075183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Formalin infiltration of the ductus arteriosus in ductus dependent cardiac anomalies (author's transl)].
    Okamoto Y; Nakayama K; Yamada K; Saito S; Haneda N; Kodama K; Osaragi M
    Kyobu Geka; 1982; 35(2):97-100. PubMed ID: 7069967
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical treatment of ductus arteriosus.
    Ivey HH; Wells HH; Kattwinkel J
    Pediatrics; 1980 Apr; 65(4):863. PubMed ID: 7367106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.